This represents a novel finding, as both basal and insulin-stimulated lipolysis were previously reported to be unchanged [11] and highlights how essential the treatment with insulin is in a prolonged and persistent manner to maximize the effects of hyperinsulinemia. The gene discussed is INS; the disease is hyperinsulinism.